Skip to main content

Phase II and III Cardiovascular Adjudication Program for Evaluation of Efficacy and Safety of VDPHL01

Clinical Trial Grant
Duke Scholars

Awarded By

VeraDermics Inc.

Start Date

February 5, 2025

End Date

February 28, 2027
 

Awarded By

VeraDermics Inc.

Start Date

February 5, 2025

End Date

February 28, 2027